Terms: = Liver cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR
437 results:
1. Prevalence of metastases outside the liver and abdominal lymph nodes on
Wedin M; Janson ET; Wallin G; Sundin A; Daskalakis K
J Neuroendocrinol; 2024 May; 36(5):e13391. PubMed ID: 38590270
[TBL] [Abstract] [Full Text] [Related]
2. The new N
Liu J; Nie W; Nie H; Yao H; Ren Y; Cao L; Qiu J; Wang M; Li X; An B; Jia X
Bioorg Chem; 2024 May; 146():107313. PubMed ID: 38554675
[TBL] [Abstract] [Full Text] [Related]
3. The global leadership into malnutrition criteria reveals a high percentage of malnutrition which influences overall survival in patients with gastroenteropancreatic neuroendocrine tumours.
Clement DSVM; van Leerdam ME; Tesselaar MET; Cananea E; Martin W; Weickert MO; Sarker D; Ramage JK; Srirajaskanthan R
J Neuroendocrinol; 2024 Apr; 36(4):e13376. PubMed ID: 38389192
[TBL] [Abstract] [Full Text] [Related]
4. Diagnostic value of liver stiffness measurement combined with risk scores for esophagogastric variceal bleeding in patients with hepatitis B cirrhosis.
Lin LY; Zeng DW; Liu YR; Zhu YY; Huang LL
Eur J Radiol; 2024 Apr; 173():111385. PubMed ID: 38377895
[TBL] [Abstract] [Full Text] [Related]
5. DNA polymerase beta connects tumorigenicity with the circadian clock in liver cancer through the epigenetic demethylation of Per1.
Chen S; Zhang W; Li X; Cao Z; Liu C
Cell Death Dis; 2024 Jan; 15(1):78. PubMed ID: 38245510
[TBL] [Abstract] [Full Text] [Related]
6. Sequencing of Somatostatin-Receptor-Based Therapies in Neuroendocrine Tumor Patients.
Strosberg JR; Al-Toubah T; El-Haddad G; Reidy Lagunes D; Bodei L
J Nucl Med; 2024 Mar; 65(3):340-348. PubMed ID: 38238038
[TBL] [Abstract] [Full Text] [Related]
7. Aggressive prostatic adenocarcinoma with urothelial-like morphology, with frequent CK7/CK20/HMWK expression and occasional diffuse neuroendocrine features: A clinicopathologic study of 12 cases.
Nguyen NJ; Sherman C; van der Kwast TH; Downes MR
Pathol Res Pract; 2024 Feb; 254():155105. PubMed ID: 38218041
[TBL] [Abstract] [Full Text] [Related]
8. Multimorbidity clusters in adults 50 years or older with and without a history of cancer: National Health Interview Survey, 2018.
Plasencia G; Gray SC; Hall IJ; Smith JL
BMC Geriatr; 2024 Jan; 24(1):50. PubMed ID: 38212690
[TBL] [Abstract] [Full Text] [Related]
9. NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic cancer: A Systematic Review and Meta-Analysis.
Nichetti F; Rota S; Ambrosini P; Pircher C; Gusmaroli E; Droz Dit Busset M; Pusceddu S; Sposito C; Coppa J; Morano F; Pietrantonio F; Di Bartolomeo M; Mariani L; Mazzaferro V; de Braud F; Niger M
JAMA Netw Open; 2024 Jan; 7(1):e2350756. PubMed ID: 38190183
[TBL] [Abstract] [Full Text] [Related]
10. Characterization of circulating miRNAs in the treatment of primary liver tumors.
Umezu T; Tanaka S; Kubo S; Enomoto M; Tamori A; Ochiya T; Taguchi YH; Kuroda M; Murakami Y
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1964. PubMed ID: 38146079
[TBL] [Abstract] [Full Text] [Related]
11. The validation of new CHD1L inhibitors as a therapeutic strategy for cancer.
Clune S; Awolade P; Zhou Q; Esquer H; Matter B; Kearns JT; Kellett T; Akintayo DC; Kompella UB; LaBarbera DV
Biomed Pharmacother; 2024 Jan; 170():116037. PubMed ID: 38128184
[TBL] [Abstract] [Full Text] [Related]
12. Real-world management practices and characteristics of patients with advanced melanoma initiated on immuno-oncology or targeted therapy in the first-line setting during the period 2015-2018 in Greece. The 'SUMMER' study: a retrospective multicenter chart review project.
Bafaloukos D; Kouzis P; Gouveris P; Boukovinas I; Kalbakis K; Baka S; Kyriakakis G; Moschou D; Molfeta A; Demiri S; Mavroudis D; Spanoudi F; Dimitriadis I; Gogas H
Melanoma Res; 2024 Apr; 34(2):152-165. PubMed ID: 38092014
[TBL] [Abstract] [Full Text] [Related]
13. Long-term quality of life is better after laparoscopic compared to open pancreatoduodenectomy.
Dagorno C; Marique L; Korrel M; de Graaf N; Thouny C; Renault G; Ftériche FS; Aussilhou B; Maire F; Lévy P; Rebours V; Lesurtel M; Sauvanet A; Dokmak S
Surg Endosc; 2024 Feb; 38(2):769-779. PubMed ID: 38052888
[TBL] [Abstract] [Full Text] [Related]
14. Combination treatment of transcatheter arterial chemoembolization, intensity-modulated radiotherapy, and sorafenib for hepatocellular carcinoma with macrovascular invasion.
Yang D; Du J; Nie W; Wang C; Ma Z
Medicine (Baltimore); 2023 Nov; 102(45):e35713. PubMed ID: 37960807
[TBL] [Abstract] [Full Text] [Related]
15. Endoscopic Rectal Ultrasound-Based Radiomics Analysis for the Prediction of Synchronous liver Metastasis in Patients With Primary Rectal cancer.
Mou M; Gao R; Wu Y; Lin P; Yin H; Chen F; Huang F; Wen R; Yang H; He Y
J Ultrasound Med; 2024 Feb; 43(2):361-373. PubMed ID: 37950599
[TBL] [Abstract] [Full Text] [Related]
16. Hepatocellular carcinoma risk in sub-Saharan African and Afro-Surinamese individuals with chronic hepatitis B living in Europe.
Patmore LA; van Eekhout KMA; Buti M; Koc ÖM; Agarwal K; de Knegt RJ; Janssen HLA; van der Valk M; Lieveld FI; Hansen BE; Kramer M; de Bruijne J; Claassen MAA; Smit C; de Man RA; Takkenberg B; Carey I; Sonneveld MJ;
J Hepatol; 2024 Feb; 80(2):243-250. PubMed ID: 37898348
[TBL] [Abstract] [Full Text] [Related]
17. Optimal first-line treatment strategies of systemic therapy for unresectable gastrointestinal neuroendocrine tumors based on the opinions of Japanese experts.
Honma Y; Ikeda M; Hijioka S; Matsumoto S; Ito T; Aoki T; Furuse J
Invest New Drugs; 2023 Dec; 41(6):777-786. PubMed ID: 37856005
[TBL] [Abstract] [Full Text] [Related]
18. The management and outcomes of hepatocellular carcinoma in sub-Saharan Africa: a systematic review.
Sobnach S; Kotze U; Spearman CW; Sonderup M; Nashidengo PR; Ede C; Keli E; Chihaka O; Zerbini LF; Li YJ; Gandhi K; Krige J; Jonas E
HPB (Oxford); 2024 Jan; 26(1):21-33. PubMed ID: 37805364
[TBL] [Abstract] [Full Text] [Related]
19. Sensitivities evaluation of five radiopharmaceuticals in four common medullary thyroid carcinoma metastatic sites on PET/CT: a network meta-analysis and systematic review.
Li P; Zhang Y; Xu T; Zhu J; Wei T; Zhao W
Nucl Med Commun; 2023 Dec; 44(12):1114-1125. PubMed ID: 37769014
[TBL] [Abstract] [Full Text] [Related]
20. [Efficacy, prognosis and influencing factors of transcatheter arterial embolization in the treatment of neuroendocrine neoplasm liver metastases].
Zhang Y; Xu RT; Bai JA; Hu P; Li XY; Tian Y; Tang QY
Zhonghua Yi Xue Za Zhi; 2023 Oct; 103(37):2952-2958. PubMed ID: 37752055
[No Abstract] [Full Text] [Related]
[Next]
